Country Profile

Haiti

Haiti is an emerging destination for Indian pharmaceutical exports — $22.2M in FY 2025–26. Medicines accounts for 89% of shipments, with vaccines contributing $1.79M.

🇭🇹 $22.2M · 0.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$22.2M
Exports FY2025–26 DGCIS
0.9×
Growth FY2015→2026
89%
Medicines Share
5
Product Categories Supplied
12
Years of Trade Data
Haiti is an emerging destination for Indian pharmaceutical exports — $22.2M in FY 2025–26. Medicines accounts for 89% of shipments, with vaccines contributing $1.79M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $19.8M (89.4%) Vaccines $1.79M (8.1%) Surgical & Hospital Supplies $503K (2.3%) Traditional & Herbal $42K (0.2%) Medicine Ingredients $29K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Haiti in the RBI overseas direct investment dataset (2011–2026).